Global Specimen Validity Testing Market – Industry Trends and Forecast to 2030

 Specimen Validity Testing Market Analysis and Size

The increasing growth of the drug screening market, rising preferences for workplace drug testing, rising cases of drug abuse around the world, and rising levels of government investment to combat drug abuse are some of the major factors that will likely boost the growth of the specimen validity testing market during the forecast period of 2023-2030. On the other hand, the introduction of point-of-care specimen validity testing will create additional opportunities, leading to the growth of the specimen validity testing market during the forecast period.

Data Bridge Market Research analyses that the specimen validity testing market which is USD 4.65 billion in 2022, is expected to reach USD 7.84 billion by 2030, at a CAGR of 6.75% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Specimen Validity Testing Market Scope and Segmentation  

Market Definition

SVT is important in health care efforts because it measures patient adherence, morale, and dependability in consultation with clinicians. SVT is commonly treated by therapists, who use the results to make treatment decisions for their patients' medical problems, such as medication and illegal drug use. In the absence of SVT, the health care provider may miss the patient's urine sample deviation in an effort to deceive the provider.

Specimen Validity Testing Market Dynamics

Drivers

• Rising number of drug screening labs

The increased number of drug screening labs and diagnostic centres, combined with effective testing methods, are some critical factors expected to drive the market, resulting in the prevalence of high drugs worldwide. Furthermore, illegal drug use, such as marijuana, heroin, cocaine, hallucinogens, and other non-medical alcoholic fluids and psychotropic medications, is raising awareness about the global specimen validity testing market. The government is also taking steps to promote drug screening programmes in the workplace for the benefit of the people, which will drive revenue growth in the specimen validity testing market during the forecast period.

• Rising usage of SVT

Law enforcement agencies use SVT to protect criminals and suspects by detecting the presence and traces of illicit drugs. It assists law enforcement agencies in studying the behaviour and causes of a specific crime. The rise in illegal drug use is driving the global specimen validity testing market. Furthermore, stringent testing laws and government funding to combat drug addiction are expected to drive the specimen validity testing market globally during the forecast period.

Opportunities

• Rise in research and development operations

The key factors driving the growth of the global specimen validity testing market are strong economic growth, an increase in disposable income, an expansion in healthcare infrastructure, and a sudden increase in investment from market players to reduce drug misuse. Growing factors for the global specimen validity testing market include drug testing laboratories expanding their research and development operations. As the number of people misusing drugs grows, so the market also grows. A presumptive test is a non-conclusive test used in criminal investigations to screen for the presence of a substance in a human body.

Restraints/Challenges

• High cost of screening tests

The prevalence of various drug screening tests and market consolidation will likely impede the growth of the specimen validity testing market during the forecast period. The time-consuming regulatory approval process for rapid testing products will be the market's biggest and most pressing challenge.

This specimen validity testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the specimen validity testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Specimen Validity Testing Market

The ongoing stress and uncertainty of COVID-19 have increased demand for psychological services in the United States, but anxiety and depression aren't the only mental health issues people are dealing with. According to experts, the misuse of opioids and stimulants is also on the rise, and psychologists are well-positioned to assist. According to an American Medical Association report, more than 40 U.S. states saw increases in opioid-related mortality in December of 2020, with ongoing concerns for those with substance use disorders. As drug use increased, the pandemic accounted for significant testing in many regions.

Global Specimen Validity Testing Market Scope

The specimen validity testing market is segmented on the basis of product and service, type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Service

• Reagents
• Calibrators
• Controls
• Assay Kits
• Disposables
• Services

 Type

• Laboratory Testing
• Rapid/PoC Testing

 End User

• Workplaces
• Drug Screening Laboratories
• Criminal Justice and Law Enforcement Agencies
• Pain Management Centers
• Drug Rehabilitation Centers
• Other End Users

Specimen Validity Testing Market Regional Analysis/Insights

The specimen validity testing market is analysed and market size insights and trends are provided by country, product and service, type, and end user as referenced above.

The countries covered in the specimen validity testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the specimen validity testing market due to the prevalence of stringent laws along with rising consumption of illicit drugs, surging levels of funds by the government to curb drug abuse.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the development of healthcare infrastructure along with rising levels of disposable income of the people.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The specimen validity testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for specimen validity testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the specimen validity testing market. The data is available for historic period 2011-2021.

Competitive Landscape and Specimen Validity Testing Market Share Analysis

The specimen validity testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to specimen validity testing market.

Some of the major players operating in the specimen validity testing market are:

• Abbott. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Puritan Medical Products (U.S.)
• BD (U.S.)
• Laboratory Corporation of America Holdings (U.S.)
• Lucence Health Inc. (Singapore)
• Hardy Diagnostics (U.S.)
• BTNX (Canada)
• Formlabs (U.S.)
• Medline Industries, Inc. (U.S.)
• VIRCELL S.L. (Spain)
• HiMedia Laboratories (India)
• Titan Biotech (India)
• McDermott Will & Emery (U.S.)
• Miraclean Technology Co. Ltd (China)
• Starplex Scientific Inc. (Canada)
• DiaSorin Molecular LLC (U.S.)

SKU-56898